NO992870L - Difenylalkyl-tetrahydropyridiner, fremgangsmåter for deres fremstilling og farmasöytiske blandinger inneholdende dem - Google Patents

Difenylalkyl-tetrahydropyridiner, fremgangsmåter for deres fremstilling og farmasöytiske blandinger inneholdende dem

Info

Publication number
NO992870L
NO992870L NO992870A NO992870A NO992870L NO 992870 L NO992870 L NO 992870L NO 992870 A NO992870 A NO 992870A NO 992870 A NO992870 A NO 992870A NO 992870 L NO992870 L NO 992870L
Authority
NO
Norway
Prior art keywords
pct
preparation
pharmaceutical compositions
compositions containing
tetrahydropyridines
Prior art date
Application number
NO992870A
Other languages
English (en)
Other versions
NO313282B1 (no
NO992870D0 (no
Inventor
Marco Baroni
Rosanna Cardamone
Jacqueline Fournier
Umberto Guzzi
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO992870D0 publication Critical patent/NO992870D0/no
Publication of NO992870L publication Critical patent/NO992870L/no
Publication of NO313282B1 publication Critical patent/NO313282B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO19992870A 1996-12-13 1999-06-11 Difenylalkyl-tetrahydropyridiner, fremgangsmåter for deres fremstilling og farmasöytiske blandinger inneholdende dem NO313282B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9615336A FR2757161B1 (fr) 1996-12-13 1996-12-13 Diphenylalkyl-tetrahydropyridines
PCT/FR1997/002289 WO1998025904A1 (fr) 1996-12-13 1997-12-12 Diphenylalkyl-tetrahydropyridines, procede pour leur preparation et composition pharmaceutique les contenant

Publications (3)

Publication Number Publication Date
NO992870D0 NO992870D0 (no) 1999-06-11
NO992870L true NO992870L (no) 1999-08-11
NO313282B1 NO313282B1 (no) 2002-09-09

Family

ID=9498642

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19992870A NO313282B1 (no) 1996-12-13 1999-06-11 Difenylalkyl-tetrahydropyridiner, fremgangsmåter for deres fremstilling og farmasöytiske blandinger inneholdende dem

Country Status (31)

Country Link
US (1) US6124318A (no)
EP (1) EP0950049B1 (no)
JP (1) JP2001505903A (no)
KR (1) KR100549656B1 (no)
CN (1) CN1144784C (no)
AT (1) ATE207056T1 (no)
AU (1) AU730142B2 (no)
BR (1) BR9713926A (no)
CA (1) CA2274946C (no)
CY (1) CY2282B1 (no)
CZ (1) CZ290242B6 (no)
DE (1) DE69707504T2 (no)
DK (1) DK0950049T3 (no)
EE (1) EE03764B1 (no)
ES (1) ES2167805T3 (no)
FR (1) FR2757161B1 (no)
HK (1) HK1024001A1 (no)
HU (1) HUP0001437A3 (no)
IL (2) IL130001A0 (no)
IS (1) IS2001B (no)
NO (1) NO313282B1 (no)
NZ (1) NZ336032A (no)
PL (1) PL192926B1 (no)
PT (1) PT950049E (no)
RS (1) RS49672B (no)
RU (1) RU2198874C2 (no)
SI (1) SI0950049T1 (no)
SK (1) SK283332B6 (no)
TR (1) TR199901290T2 (no)
UA (1) UA52708C2 (no)
WO (1) WO1998025904A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763847B1 (fr) * 1997-05-28 2003-06-06 Sanofi Sa Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1
AU2001253597A1 (en) * 2000-04-12 2001-10-30 Minerva Biotechnologies Corporation Treatment of neurodegenerative disease
US6699866B2 (en) 2001-04-17 2004-03-02 Sepracor Inc. Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof
WO2005065661A2 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Immediate, controlled and sustained release formulations of galanthamine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1321701A (en) * 1969-10-01 1973-06-27 Continental Pharma Amino-alcohols their salts and process for prepairing the same
BE775611A (fr) * 1970-11-24 1972-03-16 Synthelabo Derives de la (diphenyl-3,3 propyl-1)-1 piperidine, leur preparation etles medicaments qui en contiennent
US5266573A (en) * 1989-08-07 1993-11-30 Elf Sanofi Trifluoromethylphenyltetrahydropyridines for the treatment and/or prophylaxis of intestinal motility disorders
FR2650505B1 (fr) * 1989-08-07 1994-06-03 Midy Spa Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles de la motricite intestinale
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
US5512584A (en) * 1991-04-16 1996-04-30 Basf Aktiengesellschaft 1,3,4-trisubstituted piperidine derivatives, the preparation and use thereof
HU211019B (en) * 1991-12-02 1995-09-28 Richter Gedeon Vegyeszet Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds
DK148392D0 (da) * 1992-12-09 1992-12-09 Lundbeck & Co As H Heterocykliske forbindelser

Also Published As

Publication number Publication date
CZ290242B6 (cs) 2002-06-12
NO313282B1 (no) 2002-09-09
UA52708C2 (uk) 2003-01-15
YU26399A (sh) 2000-03-21
CA2274946A1 (en) 1998-06-18
DE69707504T2 (de) 2002-06-27
IL130001A0 (en) 2000-02-29
SK283332B6 (sk) 2003-06-03
EP0950049B1 (fr) 2001-10-17
JP2001505903A (ja) 2001-05-08
ATE207056T1 (de) 2001-11-15
CY2282B1 (en) 2003-07-04
CZ211099A3 (cs) 1999-09-15
AU5489598A (en) 1998-07-03
EE9900238A (et) 1999-12-15
IL130001A (en) 2006-04-10
WO1998025904A1 (fr) 1998-06-18
FR2757161A1 (fr) 1998-06-19
CN1240428A (zh) 2000-01-05
DK0950049T3 (da) 2002-01-28
SK78799A3 (en) 1999-12-10
IS2001B (is) 2005-04-15
FR2757161B1 (fr) 1999-03-12
NO992870D0 (no) 1999-06-11
HUP0001437A2 (hu) 2000-09-28
SI0950049T1 (en) 2002-10-31
CN1144784C (zh) 2004-04-07
RU2198874C2 (ru) 2003-02-20
EP0950049A1 (fr) 1999-10-20
KR100549656B1 (ko) 2006-02-08
US6124318A (en) 2000-09-26
IS5074A (is) 1999-06-10
TR199901290T2 (xx) 1999-08-23
ES2167805T3 (es) 2002-05-16
RS49672B (sr) 2007-11-15
NZ336032A (en) 2000-12-22
AU730142B2 (en) 2001-03-01
CA2274946C (en) 2005-09-20
BR9713926A (pt) 2000-03-21
HUP0001437A3 (en) 2001-12-28
KR20000069421A (ko) 2000-11-25
DE69707504D1 (de) 2001-11-22
PL192926B1 (pl) 2006-12-29
PT950049E (pt) 2002-03-28
PL334073A1 (en) 2000-01-31
HK1024001A1 (en) 2000-09-29
EE03764B1 (et) 2002-06-17

Similar Documents

Publication Publication Date Title
DK0794949T3 (da) Hidtil ukendte 3,5-dioxo-(2H,4H)-1,2,4-triazinderivater, fremstilling heraf og deres anvendelse som lægemidler
BR9611618A (pt) Composto processo para sua preparação composição farmacêutica e utilização de um compostos
DK0871606T3 (da) Nye forbindelser og deres præparat med anti-inflammatorisk og anti-thrombotisk aktivitet
ES2141688A1 (es) Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.
DK0810991T3 (da) 1-Aryl-2-acylamino-ethan-forbindelser og deres anvendelse som neurokinin- især neurokinin-1-antagonister
DK0784611T3 (da) N- (ortho-substitueret benzyloxy) - iminderivater og deres anvendelse som fungicider, acaricider eller insekticider
NO992870L (no) Difenylalkyl-tetrahydropyridiner, fremgangsmåter for deres fremstilling og farmasöytiske blandinger inneholdende dem
ES2124413T3 (es) Derivados de piridazinona con actividad farmaceutica.
DE69705429D1 (de) 1-phenylalkyl-1,2,3,6-tetrahydropyridine zur behandlung von alzheimerkrankheit
DK1056769T3 (da) 15-methyl-cyclopropanosteroider og fremgangsmåde til deres fremstilling